Roger Jeffs,Thomas Petersen,Roger M. Ilagan,Michael Wade
申请号：
US16002250
公开号：
US20180280445A1
申请日:
2018.06.07
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The current application is directed to a method for treating pulmonary arterial hypertension (PAH), comprising: providing isolated endothelial progenitor cells (EPCs)； treating the EPCs with prostacyclin, wherein the treated EPCs exhibit a hyperproliferative phenotype with enhanced angiogenic property； and administering a composition comprising the treated EPCs into a subject suffering from PAH.
